DENIS CHEM LAB
|
|
BOM : 537536     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : NA |
Sep 25,2023 |
Price(EOD): βΉ 108.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 151.16 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
DENIS CHEM LAB | -1.5% | -11.7% | 35.4% |
SUN PHARMACEUTICAL INDUSTRIES | -2.1% | 0.6% | 23.6% |
DIVIS LABORATORIES | -1.4% | 2% | 2% |
CIPLA | -5% | -3.3% | 8.7% |
DR REDDYS LABORATORIES | -5% | -7.9% | 30.8% |
TORRENT PHARMACEUTICALS | -2% | -5.8% | 22.5% |
ABBOTT INDIA | -2.8% | -2.2% | 24.5% |
ZYDUS LIFESCIENCES | -6.4% | -6% | 60.7% |
ALKEM LABORATORIES | -2.9% | -4.3% | 6.8% |
FUNDAMENTAL ANALYSIS OF DENIS CHEM LAB
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DENIS CHEM LAB
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
17.97
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 8.40 Cr
[Latest Qtr - Jun2023 - Standalone Results ] 2.09
P/B Calculated based on Book Value of Rs 72.26 Cr
[Latest Year - Mar2023 - Standalone Results ] 0.92
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2023 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
9% -19% -2% |
SHARE PRICE MOMENTUM OF DENIS CHEM LAB
DENIS CHEM LAB vs SENSEX
DEBT OF DENIS CHEM LAB
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.05 0.14 0.23 0.14 |
- - - - |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF DENIS CHEM LAB
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF DENIS CHEM LAB
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
6.93% 5.9% 206.11% 245.94% |
8.12% 16.65% 17.6% 24.93% |
QtrlyTrend |
8 | |
Latest Qtr: Jun2023 | ||
Quarterly Result Analysis → |
DENIS CHEM LAB related INDICES
You may also like the below Video Courses
FAQ about DENIS CHEM LAB
Is DENIS CHEM LAB good for long term investment?
As on Sep 25,2023, the Fundamentals of DENIS CHEM LAB look Poor and hence it may not be good for long term investment ! See Financial Performance of DENIS CHEM LAB . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DENIS CHEM LAB UnderValued or OverValued?
As on Sep 25,2023, DENIS CHEM LAB is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of DENIS CHEM LAB ?
As on Sep 25,2023, the Intrinsic Value of DENIS CHEM LAB is Rs. 110.56 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 100.05
Fair Value [Median EV / Sales Model] : Rs. 133.52
Fair Value [Median Price / Sales Model] : Rs. 110.56
Estimated Median Fair Value of DENIS CHEM LAB : Rs. 110.56
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is DENIS CHEM LAB trading at a Premium or Discount?
As on Sep 25,2023, DENIS CHEM LAB is trading at a Discount of -2% based on the estimates of Median Intrinsic Value!